Kelly Bilodeau on Muck Rack

Kelly Bilodeau

Boston
As seen in: The Washington Post, Harvard Health Publishing, Yahoo Finance, Yahoo, St. Louis Post-Dispatch, Arizona Daily Star, Omaha World-Herald, Richmond Times-Dispatch, Buffalo News, CMSWire and
Mom, wife, freelance writer.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kelly

Contact Kelly, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Don't miss the most important voices in pharma Original

|
By Kelly Bilodeau
| PharmaVOICE
This audio is auto-generated. Please let us know if you have feedback. Personalized cancer treatments, cell and gene therapies and regenerative medicine often don’t fit neatly into a traditional drug approval pathway. So China has established a new approval track to give local patients faster access to emerging innovations.
Open in Who Shared View Duplicates (3) Issue with article?

Don't miss the most important voices in pharma Original

|
By Kelly Bilodeau
| PharmaVOICE
This audio is auto-generated. Please let us know if you have feedback. The high-stakes bidding war that culminated last year between Novo Nordisk and Pfizer to acquire Metsera provided a clear illustration of just how motivated large pharmas are to stake their claim on up-and-coming candidates in the obesity space.
Open in Who Shared View Duplicates (2) Issue with article?

Don't miss the most important voices in pharma Original

|
By Kelly Bilodeau
| PharmaVOICE
This audio is auto-generated. Please let us know if you have feedback. It’s not every day that drug companies need to worry about a treatment working too well, but in a recent trial for a new Eli Lilly weight-loss treatment, some slimmer patients had to drop out for fear of shedding too many pounds.
Open in Who Shared View Duplicates (2) Issue with article?
See all 1,228 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Kelly

Contact Kelly, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified